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Detection and characterization of 
mineralo-organic nanoparticles in 
human kidneys
Tsui-Yin Wong1,2,*, Cheng-Yeu Wu1,2,3,*, Jan Martel1,2,*, Cheng-Wei Lin1,2, Fu-Yung Hsu4, 
David M. Ojcius2,5, Paul Y. Lin6 & John D. Young1,2,7,8
Ectopic calcification is associated with various human diseases, including atherosclerosis, cancer, 
chronic kidney disease, and diabetes mellitus. Although mineral nanoparticles have been detected in 
calcified blood vessels, the nature and role of these particles in the human body remain unclear. Here 
we show for the first time that human kidney tissues obtained from end-stage chronic kidney disease 
or renal cancer patients contain round, multilamellar mineral particles of 50 to 1,500 nm, whereas no 
particles are observed in healthy controls. The mineral particles are found mainly in the extracellular 
matrix surrounding the convoluted tubules, collecting ducts and loops of Henle as well as within 
the cytoplasm of tubule-delineating cells, and consist of polycrystalline calcium phosphate similar 
to the mineral found in bones and ectopic calcifications. The kidney mineral nanoparticles contain 
several serum proteins that inhibit ectopic calcification in body fluids, including albumin, fetuin-A, 
and apolipoprotein A1. Since the mineralo-organic nanoparticles are found not only within calcified 
deposits but also in areas devoid of microscopic calcifications, our observations indicate that the 
nanoparticles may represent precursors of calcification and renal stones in humans.
Ectopic calcification is associated with atherosclerosis, cancer, chronic kidney disease, and diabetes mel-
litus1–3. Recent studies indicate that atherosclerosis and chronic kidney disease patients with signs of 
vascular calcification show increased morbidity and mortality risks, suggesting that ectopic calcification 
is detrimental to human health1,3. Unwanted calcification is also observed in aging individuals, and most 
people over the age of 60 show signs of vascular calcification4. For these reasons, deciphering the factors 
that induce ectopic calcification and developing effective treatment represent important goals.
Ectopic calcification can be defined as an imbalance between inhibitors and inducers of calcification 
in the body. Calcification inhibitors include serum proteins such as albumin, fetuin-A, osteopontin, 
and matrix gla protein as well as small compounds like pyrophosphate, whereas hyperphosphatemia 
and inflammation represent major inducers of calcification5–7. Recent studies indicate that calcification 
inducers activate a cellular process similar to bone formation during vascular calcification7,8. Matrix 
vesicles similar to the ones that induce mineralization in developing bones have also been detected in 
calcified soft tissues7–9. These matrix vesicles are probably released by vascular smooth muscle cells that 
differentiate into osteoblast-like cells, which induce calcification7.
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Mineral nanoparticles (NPs) have been detected in soft tissues showing signs of ectopic calcification. 
Price et al. found that the serum of rats treated with either the bisphosphonate etidronate or with vita-
min D harbor mineralo-protein complexes containing the calcification inhibitors fetuin-A and matrix 
gla protein10,11. Similarly, Jahnen-Dechent et al. observed that fetuin-A-containing mineral complexes, 
which were called calciprotein particles (CPPs), could be detected in the ascitic fluid of patients with 
calcifying peritonitis12. A recent study by Bertazzo et al. demonstrated the presence of mineral NPs in 
the aortic valves and coronary arteries of both atherosclerotic and rheumatic fever patients13. While 
studies on the formation of mineral particles have usually focused on the human cardiovascular system, 
it remains unclear whether the particles may be found in other tissues and whether these entities play a 
role in health or disease.
We observed earlier that mineralo-organic NPs spontaneously form in human and animal body flu-
ids14–28. These mineral NPs were initially described as nanobacteria (NB) and were believed to be not 
only the smallest cells on earth29, but also a possible transmissible cause of numerous diseases, includ-
ing Alzheimer’s disease, atherosclerosis, cancer, kidney stone formation, polycystic kidney disease, and 
prostatitis30–32. However, our results have shown that NB are in fact non-living mineral NPs that mimic 
common bacteria in terms of their morphology, growth, proliferation, and sub-culture15,18,22. The pos-
sibility that mineral particles similar to the so-called NB may be found in human tissues and whether 
these particles play a role in disease remains to be examined.
In the present study, we developed a nanomaterial approach to detect and analyze mineralo-organic 
NPs in diseased human kidney tissues. We show that kidney tissues from end-stage chronic kidney dis-
ease and renal cancer patients contain multilamellar mineral NPs similar to the biomimetic mineral par-
ticles that spontaneously precipitate in body fluids in vitro. Our results reveal critical insights concerning 
the biochemical composition, mechanism of formation and biological function of these mineralo-organic 
particles and they shed light on mechanisms of ectopic calcification and initiation of disease in the 
human body.
Results
We examined kidney tissues surgically removed from human patients with either end-stage chronic 
kidney disease (n = 2) or renal cancer (n = 18; see Table 1; for renal cancer samples, we focused on the 
non-cancerous part of the tissue). As healthy controls, we studied kidney biopsies obtained from patients 
with either trauma or hematoma but who had no prior abnormal renal function (n = 2; Table 1).
Kidney tissues from healthy individuals showed normal histological features, and no ectopic calcifica-
tion was observed following von Kossa staining (Fig. 1A,B). On the other hand, kidney tissues obtained 
from diseased individuals and stained with hematoxylin and eosin (H&E) showed evidence of tissue 
damage (Fig. 2A–C, indicated by arrows), and 80% of the diseased tissues examined showed mineralized 
deposits as revealed by von Kossa staining (Fig. 1C–T, Fig. 2E,F, calcification is visible as black material 
indicated by black arrows; see also Table 1). Calcified deposits were noticed in the cortex and medulla, 
including the extracellular space surrounding the distal convoluted tubules, proximal convoluted tubules, 
collecting ducts and loops of Henle as well as the cytoplasm of cells delineating the tubules and ducts 
(Fig. 1C–T and Fig. 2E,F). No calcification was detected in the renal corpuscle (Fig. 2D).
To examine the nature of the mineral precipitates, we prepared ultra-thin kidney sections for observa-
tion by transmission electron microscopy (TEM). In specimens containing microscopic mineral deposits, 
mineral particles or granules were detected in the cytoplasm of renal epithelial cells, in the extracellular 
matrix beneath the basement membrane, and within the lumen of proximal and distal convoluted tubules 
(Fig. 3A,B, particles are enlarged in panels A1–A4 and B1–B4). Mineral NPs were also observed within 
cells lining the loops of Henle and collecting ducts (Fig. 3C,D, enlarged in panels C1, C2, and D1). Some 
particles were found within intracellular vesicles in renal cells (Fig. 3A, panels A1 and A2). The electron 
microscopy approach used here also allowed us to visualize the interior of the mineral particles; some 
particles harbored electron-dense rings alternating with light, electron-lucent layers (Fig. 3A, panels A3 
and A4, Fig. 3C, panel C1). Several blood vessels, such as the vasa recta renis (the straight arteries of the 
kidney), were surrounded by large numbers of mineral NPs (Fig. 3D, panel D1). Mineral NPs were thus 
found at various locations in all human kidney tissues showing signs of ectopic calcification, whereas no 
particles were found in the healthy controls examined.
The mineral particles found in kidney tissues appear to be very similar to the mineralo-organic NPs 
described to form spontaneously in body fluids in our previous studies15,17 (and which we have termed 
bions24). To verify this possibility, we prepared mineralo-organic NPs (or bions) using a precipitation 
method as we previously described15. This method consists of adding precipitating ions like calcium 
and phosphate into a cell culture medium (Dulbecco’s modified Eagle’s medium or DMEM) containing 
a body fluid like human serum (HS), followed by incubation in cell culture conditions (see Methods). 
The particles produced this way (HS-NPs) were either spherical or ellipsoid and showed a smooth or 
crystalline mineral surface (Fig. 4A–E), similar to the particles described earlier in body fluids22,23 as well 
as in human ascites12 and calcified arteries13. The mineral particles were very similar to the mineral NPs 
or granules observed in kidney tissues in terms of their overall morphology, multilayer structure, and 
surface characteristics (Fig. 4F–J). The size of HS-derived particles and kidney granules were also com-
parable, varying from 50 to 1,500 nm in diameter (Fig. 4A–E,F–J). As noted above, some kidney granules 
were surrounded by a lipid membrane, possibly representing intracellular cargo vesicles or extracellular 
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membrane vesicles (Fig.  4H,I, membranes are denoted by arrows); such membranous structures were 
absent in HS-NP specimens prepared in vitro (Fig. 4A–E). These observations suggest that kidney gran-
ules are similar to the mineralo-organic NPs assembled in serum.
Using selected area electron diffraction analysis, we observed that the mineral phase of HS-NPs pre-
pared in vitro consisted of a polycrystalline nanomaterial (Fig.  4E, inset; notice the faint concentric 
rings). Similar results were obtained for kidney granules (Fig. 4J, inset) and for bones and ectopic calci-
fications as described in previous studies33,35.
We studied the chemical composition of HS-NPs and kidney granules using energy-dispersive X-ray 
spectroscopy (EDX). HS-NPs showed major peaks of carbon (C), calcium (Ca), oxygen (O), and phos-
phorus (P) (Fig. 4K), consistent with the presence of a calcium phosphate mineral. A low peak of silicon 
(Si) was also noted in HS-NPs (Fig.  4K), possibly representing a minor particle constituent. Kidney 
granules also showed peaks of carbon, calcium, oxygen and phosphorus, indicative of a calcium phos-
phate mineral, along with additional peaks of silicon and iron (Fe) (Fig. 4L). Uranium peaks (U) were 
attributed to the uranyl acetate used as contrasting reagent during sample preparation (the presence of 
uranium in some samples of mineral particles like kidney granules and its absence in the control tissue 
in Fig.  4M may be attributed to the high affinity of uranium for phosphate, as reported previously35). 
Control EDX spectra of kidney tissue surrounding the particles showed peaks of carbon and oxygen 
(Fig. 4M), suggesting that calcium and phosphorus were found mainly in the mineral particles.
Calcium:phosphorus (Ca:P) ratios of HS-NPs and kidney granules varied from 0.65 to 1.18. These 
ratios differ from the theoretical value of 1.67 observed for stoichiometric hydroxyapatite but are still 
within the range seen earlier for calcium phosphate and apatite crystals observed at various degrees of 
# Age Gender
BUN 
(mg/dl) 
[6–21]
Creatinine 
(mg/dl) 
[M<1.27; 
F<1.03]
Albumin 
(g/dl) 
[3.5–5.5]
Total 
Cholesterol 
(mg/dl) 
[<200]
Urine 
Protein 
(mg/day) 
[50–80]
Urine 
Albumin 
(mg/dl)
Clinical 
Diagnosis
von Kossa 
Staining 
and NP 
Detection
1 25 F – – – – – – Trauma Negative
2 39 F – 0.66 4.1 – – – Hematoma Negative
3 74 F 31 5.78 – – – – ESKD Positive
4 56 M – – – – – – ESKD Positive
5 77 M 26 1.75 4.2 – – – TCC Positive
6 79 M – 2.50 – – – – TCC Negative
7 65 M 103 10.52 – – – 3+ (300) RCC (T1b) Positive
8 85 M 19 0.95 – 227 – – RCC (T1b) Positive
9 66 F – 1.10 – – – – TCC (T1a) Positive
10 79 F 19 1.20 4.4 – – 1+ (30) TCC (T1a) Negative
11 69 M 19 1.94 3.6 – – – TCC (T1) Positive
12 74 M – 1.30 – – – – TCC (T3) Negative
13 76 F 70 7.68 4.6 208 117 25 TCC (T1a) Positive
14 63 M 16 2.52 – – – – TCC (T3) Positive
15 61 F – 1.54 – – – – TCC (T1a) Negative
16 66 F 15 1.04 – – – – TCC (T3) Positive
17 62 F 53 8.50 4.0 – – 150 TCC (T2) Positive
18 79 F 8 0.90 2.7 – – 150 TCC Positive
19 67 F 23 1.52 3.7 – – – TCC Positive
20 79 F 38 4.02 – – – 150 TCC (T1) Positive
21 86 M – – – – – – TCC Positive
22 72 F 20 1.53 – – – – TCC Positive
Table 1.  Information on human kidney tissue donor and ectopic calcification status. The range of 
normal renal test values is given within brackets. Renal cancer staging is given within parentheses in the 
“Clinical Diagnosis” column. von Kossa staining was considered positive when black precipitates were 
detected by optical microscopy; NP detection was confirmed using TEM. Biopsies from hematoma and 
trauma patients with no history or sign of kidney function abnormalities were used as healthy controls. 
Staging of renal cancer from stages 1 to 4 (T1–T4) is given within parentheses. The dash symbol (–) denotes 
unavailable information. Abbreviations: BUN: blood urea nitrogen; M: male; F: female; NP: nanoparticle; 
ESKD: end-stage kidney disease; TCC: transitional cell carcinoma; RCC: renal cell carcinoma.
www.nature.com/scientificreports/
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crystallization15. Together, these findings confirm that the kidney granules consist of calcium phosphate 
NPs.
Various proteins have been found to inhibit ectopic calcification in a systemic manner in the body36,37. 
In addition, the protein corona found on the surface of synthetic NPs is believed to determine the biodis-
tribution and effects of the particles on cells in vivo38,39. On the other hand, the protein composition of 
mineralo-organic NPs found in human kidney tissues remains incompletely understood. We found pre-
viously that albumin, fetuin-A and apolipoprotein-A1 (apo-A1) represent the main proteins that interact 
with mineralo-organic NPs formed in body fluids17,20. Here we used immunogold labeling to examine 
the presence and ultrastructural location of these proteins within kidney granules.
We used polyclonal antibodies against human serum albumin (HSA), human serum fetuin-A (HSF), 
human apo-1A, and whole HS to examine the presence of serum proteins in HS-NPs and kidney gran-
ules. The specificity of the polyclonal antibodies (prepared as described earlier25) was verified using 
Western blotting (Fig.  5). Each one of the polyclonal antibodies reacted positively with the HS-NPs 
prepared in vitro as well as with the mineral granules found in human kidney tissues (Fig. 6A,B, panels 
A1–A3 and B1–B3; black dots). The antibodies reacted mainly with the electron-dense layers or the dark 
core of HS-NPs and kidney granules (Fig.  6A,B), indicating that these dark areas may contain higher 
levels of proteins compared with electron-lucent areas. Negative controls performed without primary 
antibody produced no reaction (Fig. 6A,B, panels A4 and B4, control). We concluded that kidney gran-
ules represent mineralo-organic NPs similar to HS-NPs based not only on their morphology and mineral 
composition but also on their binding to the major calcification inhibitors present in serum.
Immunofluorescence microscopy was used next to confirm the presence of mineral granules con-
taining HSA and HSF in diseased human kidneys. Using this technique, human kidney tissues showed 
Figure 1. von Kossa staining of human kidney tissues. Kidney tissues were processed for von Kossa 
staining as described in Methods. Positive staining was based on the observation of black precipitates under 
optical microscopy (black arrows). Tissues in (A,B) consist of healthy controls; (C,D) correspond to patients 
with end-stage kidney disease; (E–T) tissues from renal cancer patients. Tissues from two additional cases of 
renal cancer are shown in Fig. 2. Scale bars: 10 μ m.
www.nature.com/scientificreports/
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positive staining for the two proteins in various areas, including the interstitium surrounding renal 
tubules as well as the cytoplasm of tubule-delineating cells (Fig. 7A, panels A1 and A2). Protein aggre-
gates containing both albumin and fetuin-A were also noticed in these areas, albeit in lower amounts 
compared to the staining of the single proteins (Fig.  7A and panel A3, merged staining in yellow). 
Notably, we noticed that the protein staining detected by immunofluorescence closely overlapped with 
the pattern of ectopic calcification observed using von Kossa staining (Fig. 7A,B, calcification is visible 
as black material indicated by arrows in B). These results provide further support for the presence of 
mineralo-organic particles in the human kidney tissues examined.
Discussion
While advances have been made in our understanding of the interactions between synthetic NPs and 
human cells, we know considerably less about the effects of mineralo-organic NPs that form sponta-
neously in body fluids. Our previous studies have shown that these particles form in biological fluids 
when the concentrations of calcium and phosphate exceed saturation15,16. We also observed that these 
particles are internalized by immune cells but that only large particles induce pro-inflammatory immune 
reactions23. However, the distribution of these particles in human tissues and whether they play any 
physiological or pathological roles in the body had not been examined so far.
In the present study, we detected for the first time mineralo-organic NPs in kidneys of human patients 
suffering from either end-stage kidney disease or renal cancer. The mineralo-organic NPs detected con-
tain poorly crystallized calcium phosphate similar to bone mineral, as well as albumin, fetuin-A and 
apo-A1 which act as systemic calcification inhibitors in body fluids. Our results are in agreement with 
previous reports that described the presence of mineral-protein complexes in vascular tissues and body 
fluids12,13,34,40. Since the particles that we observed were found in areas containing no microscopic calci-
fications, our observations suggest that the particles may represent precursors of ectopic calcification in 
human tissues. Given the possibility that mineralo-organic NPs may gradually grow in size and undergo 
a particle-to-film conversion under favorable conditions as described in our previous studies15,18, the 
observations presented here suggest that the mineral precursors may lead to the formation of larger 
mineral deposits in vivo, such as Randall’s plaque and kidney stones.
Figure 2. Mineral deposits found in diseased human kidneys. (A–C) H&E staining of human kidney 
tissues obtained from renal cancer patients. Hollow arrows indicate areas with cellular damage. (D–F) von 
Kossa staining of human kidney tissues. Mineral precipitates indicated by black arrows were found in the 
cortex (E) and medulla (F) but were absent in the renal corpuscle (D). Ectopic mineralization was found 
mainly in the basal membrane and interstitium surrounding the PCT, DCT, LH, and CD. Abbreviations: BC, 
Bowman’s capsule; BS, Bowman’s space; BV, blood vessel; CD, collecting duct; DCT, distal convoluted tubule; 
G, glomerulus; IA, interlobular artery; LH, loop of Henle; PCT, proximal collecting tubule. Scale bars: 10 μ m.
www.nature.com/scientificreports/
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Our observations that mineral ectopic calcifications and mineralo-organic NPs are found in vari-
ous anatomical structures of the kidneys are consistent with previous findings of ectopic calcifications 
in this organ41. Evan et al.’s observations indicated that mineralization in the kidneys of patients with 
nephrolithiasis may start and occur predominantly in the interstitial tissue of the loops of Henle40,42. 
These authors observed that mineral deposits forming in this area may protrude from the basal side of 
the urothelium and lead to the formation of kidney stones. Our observations suggest that, in addition to 
the loops of Henle, other kidney areas may contain mineral NPs which may eventually evolve to form 
large mineral deposits in human kidneys. We are also investigating the possibility that mineral NPs that 
form in the blood circulation may translocate into renal tissues and induce ectopic calcification and stone 
formation in kidneys.
Several kidney granules detected in the present study are found within intracellular or extracellular 
vesicles (Fig.  4H,I) and these are similar to the matrix vesicles shown to induce calcification in bones 
and teeth7,8. We recently observed that vesicles isolated from human and animal serum induce the 
formation of mineral NPs and microscopic precipitates in vitro25. Schlieper et al.34 also observed that 
mineral particles found in arteries are associated with membrane structures and proposed that matrix 
vesicles or apoptotic bodies may represent nucleators of mineral particles in these tissues. Similarly, Khan 
Figure 3. Ultrastructural localization of mineral NPs in diseased human kidney tissues. (A–D) Human 
kidney tissues were prepared for thin-section TEM as described in Methods. Mineral NPs were observed in 
the cytoplasm of epithelial cells as well as in the extracellular matrix and lumen of (A) PCT, (B) DCT, (C) 
LH, and (D) CD. Images A1-A4, B1-B4, C1, C2, and D1 correspond to enlarged sections denoted by white 
rectangles in panels (A–D). Note that the particles in A1 and A2 are surrounded by a cellular membrane. 
The VR in panel D1 is surrounded by a large number of NPs. Abbreviations: N, nucleus; VR, vasa recta 
renis.
www.nature.com/scientificreports/
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et al. reported that calcium phosphate deposits found in the kidneys of human patients with idiopathic 
kidney stones are associated with collagen fibers and matrix vesicles9. These results suggest that the 
mineralo-organic NPs detected in kidney tissues may form via a mechanism involving membrane vesi-
cles, a situation analogous to what is seen in atherosclerotic arteries7,8. On the other hand, a recent study 
showed that ectopic calcification found in women breast arteries was not associated with osteogenic or 
apoptotic cell markers43, suggesting that the mechanism of calcification may be specific to the organ 
or biological context involved. In addition, mineralo-organic NPs such as the ones described here in 
human kidney tissues may also form due to a failure to maintain physiological concentrations of ions 
(e.g., calcium and phosphate) and calcification inhibitors (e.g., albumin, fetuin-A, and apo-A1) in human 
body fluids.
Our results suggest that the electron-dense layer and core of mineralo-organic NPs may contain 
higher levels of proteins and organic molecules compared to the electron-lucent areas of the particles 
(Fig. 6A,B). These electron-dense layers appear to be mineralized as seen by the crystalline nature of this 
material under TEM (see Fig. 4A–J). Other authors, including Ryall41 and Evan et al.44, have proposed 
that the electron-lucent layer may represent minerals while electron-dense layers may correspond to 
organic molecules. These interpretations may be due at least in part to the manner in which the samples 
were processed and examined in each study as well as the nature of the starting tissues used.
In addition to playing a role in ectopic calcification, mineralo-organic particles may induce inflam-
mation in kidney tissues. We have shown recently that while mineralo-organic NPs fail to induce the 
secretion of pro-inflammatory interleukin-1β by human macrophages, mineral aggregates larger than 
1 μ m are able to do so23. The release of interleukin-1β in response to crystalline materials has been 
shown to rely on the activation of intracellular molecular complexes termed the inflammasomes45–47. In 
Figure 4. Morphology and chemical composition of mineralo-organic NPs and mineral particles found 
in kidney tissues. (A–E) Mineralo-organic NPs labeled as HS-NPs were prepared by adding 3 mM CaCl2 
and Na2HPO4 each into DMEM containing 10% HS, followed by incubation for one week in cell culture 
conditions. TEM observations of HS-NP thin sections showed round particles with a smooth or crystalline 
surface. (F–J) Mineral particles or granules observed in human renal tissues by thin-section TEM. Kidney 
NPs or granules showed morphologies and sizes similar to that of HS-NPs. Some kidney granules were 
surrounded by a lipid membrane ((H,I) black arrows) while membranes were not observed in HS-NP 
specimens prepared in vitro. Representative electron diffraction patterns are shown in (E) and (J) (insets). 
EDX analysis of (K) prepared HS-NPs, (L) kidney granules found in human renal tissues, and (M) control 
kidney tissues. White stars indicate the areas selected for EDX analysis. Both HS-NPs and kidney granules 
show major peaks of carbon, calcium, oxygen and phosphorus along with other minor peaks, consistent 
with the presence of calcium phosphate containing additional ions. (M) EDX spectrum of control tissues 
surrounding the particles show no calcium or phosphate peaks. Ca:P ratios: (K) 1.18; (L) 0.65.
www.nature.com/scientificreports/
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addition, the mineral particles were detected in kidneys harboring tumors and the association between 
cancer and inflammation is now well recognized48. The possibility that aggregated mineral particles may 
activate an inflammasome and contribute to the development of inflammation and cancer in kidneys or 
other tissues remains to be investigated.
In addition to ectopic calcification, the mineral granules described here may participate in other 
disease processes. For instance, we have proposed earlier that mineral NPs may bind to various proteins 
in body fluids and deplete these organic molecules from body fluids20,26. On the other hand, the human 
body may prevent the formation and accumulation of mineral NPs under normal circumstances by rely-
ing on the presence of calcification inhibitors and the reticuloendothelium system (i.e., macrophages). 
Mineral NPs may thus accumulate only once systemic or local calcium homeostasis is perturbed and 
when the protective mechanisms have failed in the human body.
We propose that the nanomaterial approach developed here may be used to study the formation of 
mineralo-organic NPs in animal and human tissues. For instance, antibodies raised against calcification 
inhibitor proteins such as albumin, fetuin-A and apo-A1 may be used in combination with mineral 
analysis to detect and characterize the formation of mineralo-organic NPs in the tissues of animal mod-
els. The results obtained using this approach may be applied to clinical measurements made on human 
body fluids in order to identify biological parameters that reflect the state of mineral particle formation 
and ectopic calcification in the body. We expect that this knowledge may lead to the development of 
novel therapeutic strategies to prevent and treat human diseases and conditions associated with ectopic 
calcification.
Methods
Kidney tissues. The use of human tissues and the experiments performed in this study were approved 
by the Institutional Review Board of Chang Gung Memorial Hospital; the methods and experiments were 
carried out in accordance with the approved guidelines. Written informed consent was obtained from the 
patients. Control healthy kidney tissues were obtained from biopsies of trauma and hematoma patients 
with no history of kidney disease (n = 2); kidney tissues were also obtained from renal cancer patients 
(n = 20) and from end-stage kidney disease patients (n = 2) whose kidneys were removed or biopsied 
during transplant surgery (Table  1). For renal cancer tissues, the non-cancerous part of the tissue was 
dissected and analyzed in the present study.
Figure 5. Specificity of polyclonal antibodies against serum proteins. (A–D) Polyclonal antibodies were 
prepared in rabbits as described earlier25. Western blotting was performed in reducing and denaturing 
conditions as described in Methods. A control specimen containing only mineral NPs was used in lane 1. 
Reactions against HSA, HSF, and human apo-A1 are indicated with a black triangle, a white triangle, or 
a black circle, respectively. (A) The anti-HSA antibody (α -HSA) reacted with a single band of 85 kDa in 
whole HS, HS-NPs and purified HSA but produced no reaction against a negative control of mineral NPs 
or HSF. The anti-HSF antibody (α -HSF) reacted with a 62-kDa band in whole HS and HS-NPs and with 
two bands of 55 and 62 kDa in HSF ((B) the presence of multiples bands for purified HSF was attributed 
to glycosylation which may affect protein migration). (B) No reaction was noted for the anti-HSF antibody 
against the negative NP control or HSA. (C) The anti-apo-A1 antibody (α -h Apo-A1) reacted with a 30-
kDa band in whole HS and HS-NPs but produced no reaction against mineral NPs, HSA, or HSF. (D) The 
polyclonal anti-HS antibodies reacted with three bands of 30, 58, and 75 kDa in whole HS and HS-NPs 
(these protein bands likely corresponded to HSA, HSF, and apo-A1, respectively). In addition, the anti-HS 
antibody mainly produced a 75-kDa band against HSA and a 55-kDa band in the lane containing HSF. 
Given that purified proteins were used and that the molecular weights observed for HSA, HSF, and apo-
A1 correspond to the molecular weight observed for these proteins in previous studies15,16 (approximately 
28, 55, and 72 kDa, respectively), these results suggest that the polyclonal antibodies reacted positively and 
specifically against the serum proteins used as antigens.
www.nature.com/scientificreports/
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Histological analysis. Kidney tissues were mounted on paraffin blocks. The blocks were sectioned 
and tissue slices were heated on a hot plate at 70 °C for 30 min to remove paraffin. The sections were 
immersed into a fresh solution of xylene three times for 15 min to completely remove the remaining 
Figure 6. Immunogold staining of mineralo-organic NPs and kidney granules. (A) HS-NPs prepared as 
in Fig. 4 and (B) human kidney tissues were processed for thin-section TEM and immunogold labeling. The 
antibodies used are indicated at the bottom right corner of each panel. Treatment without primary antibody 
was used as a negative control (panels A4 and B4).
Figure 7. Immunofluorescence and von Kossa staining of human kidney tissues. (A) Polyclonal antibodies 
whose specificity was evaluated in Fig. 5A,B were used to stain renal tissues. Primary antibodies against HSA 
and HSF reacted with a secondary antibody labeled respectively with a red or green fluorophore in panels 
A1 and A2. Merged staining is shown in yellow (panels A, A3, and A4). Cell nuclei were stained with DAPI 
(blue). The images showed positively-stained tubules. Dots of proteineous particles were found in epithelial 
cells, cell cytoplasm, nuclei, and brush-like structures close to the lumen. (B) kidney tissues were stained 
with von Kossa. The pattern of ectopic calcification observed in (B) appeared to overlap to some extent with 
the merged yellow staining detected in (A), suggesting the presence of mineralo-organic particles in the cell 
cytoplasm and interstitium (hollow and black arrows).
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paraffin. The sections were rehydrated with 95%, 80%, and 70% ethanol for 5 min each time. Rehydrated 
specimens were washed with double-distilled water (ddH2O) for 5 min. Cell nuclei were stained with 
hematoxylin for 8 min. The dye was removed from the specimens with warm water for 10 min. Kidney 
specimens were rinsed in ddH2O and were dipped 10 times in 95% ethanol. The ethanol-treated spec-
imens were counter-stained with eosin Y for 1 min. Specimens were dehydrated with 95% and 100% 
ethanol for 10 min each time, followed by a dehydration step in xylene for 10 min. The final dehydrated 
kidney specimens were mounted on glass slides with 50% glycerol and observed under a light micro-
scope equipped with a digital camera.
De-paraffinized and rehydrated specimens were prepared as described for H&E staining. Rehydrated 
sections were stained with silver nitrate (5%), followed by exposure to UV light for 20 min. The solu-
tion was washed with ddH2O for 15 min. The sections were stained with sodium thiosulfate (5%) for 
5 min, followed by washing with ddH2O for 15 min. The sections were stained with nuclear fast red 
(Sigma-Aldrich, St. Louis, MI) for 5 min. Stained specimens were dehydrated successively with 95% 
and 100% ethanol for 10 min each, prior to dehydration in xylene for 10 min. Kidney specimens were 
mounted onto glass slides and examined as described above.
Electron microscopy and EDX analysis. Kidney samples were cut into small pieces less than 1 mm 
thick using a LGPS dissection microscope (Olympus, Tokyo, Japan). The tissues were fixed with 2.5% glu-
taraldehyde and 1% paraformaldehyde in 0.1 M cacodylate buffer at 4 °C overnight. Fixed samples were 
washed three times with 0.1 M cacodylate buffer in 8% sucrose (pH 7.2) on ice for 10 min. Washed tissues 
were incubated in phosphate-buffered saline (PBS; 137 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4) con-
taining 1% osmium tetroxide and 1.5% potassium ferrocyanide for 2 h on ice. The tissues were washed 
with ddH2O on ice for 10 min three times. Washed tissues were stained on ice with 1% uranyl acetate 
in ddH2O for 1 h, prior to washing three times with ddH2O on ice. Kidney tissues were dehydrated with 
30, 50, 70, 80, and 90% ethanol for 10 min each time, except when ethanol reached 70%, in which case 
the samples were stored at 4 °C overnight. Tissues were stained with 1% phosphotungstic acid in 95% 
ethanol for 15 min, prior to dehydration with 95% ethanol for 5 min. The specimens were immersed into 
propylene oxide at 40, 57, 67, and 100% in ethanol for 10 min each time, followed by another immersion 
in 100% propylene oxide for 5 min. Kidney tissues were infiltrated with 50, 70, and 100% Eponate 812 
(Ted Pella, Redding, CA) for 1 h each time. Eponate 812-embedded kidney samples were prepared by 
incubating twice into 100% Eponate. Embedded samples were incubated into an oven at 60 °C overnight 
to allow resin polymerization.
Washed HS-NP pellets obtained as above were fixed with glutaraldehyde (2.5%) and paraformal-
dehyde (1%) in ddH2O for 4 h at 4 °C. Fixed pellets were washed with ddH2O three times for 10 min 
each time. Pellets were dehydrated with successive incubations into 30, 50, 70, 80, 90, 95, and 100% 
ethanol, for 10 min each time, except when ethanol reached 70%, in which the pellets were stored at 
4 °C overnight. Other ethanol solutions were only put in contact with the pellets for 10 min. Dehydrated 
pellets were infiltrated with LR white embedding medium (Electron Microscopy Sciences, Hatfield, PA) 
using different ratios of ethanol and LR medium (3:1, 1:1, and 1:3) for 30 min each. The pellets were 
infiltrated with fresh LR medium (100%) overnight before polymerization. Pellets infiltrated with LR 
medium were incubated in an oven at 60 °C for 2 days to allow resin polymerization. Blocks of kidney 
and HS-NPs were sectioned to produce slices with a thickness of 70–100 nm using a Reichert Ultracut S 
microtome (Leica, Wetzlar, Germany). Tissue sections were stained with 4% uranyl acetate before visu-
alization under a JEM 1230 transmission electron microscope (JEOL, Tokyo, Japan) operated at 100 kV. 
Electron diffraction patterns were obtained using the same system. Nickel grids were used as a support.
For EDX analysis, thin sections of kidney tissues were stained with uranyl acetate and washed with 
ddH2O as above, followed by drying in an electronic dessicator cabinet. Specimens were observed under 
a high-resolution JEM 2100 transmission electron microscope (JEOL) operated at 120 kV. EDX spectra 
were obtained in triplicate using an INCA Energy EDS system (Oxford Instruments, Abingdon, UK). 
Thin sections of HS-NPs were observed without staining.
Preparation of mineralo-organic NPs. All starting solutions were adjusted to pH 7.4 and sterilized 
by filtration through 0.2 μ m membranes prior to use. HS was obtained from healthy human volun-
teers using a conventional venipuncture technique. The use of human biological fluids in this study 
was approved by the Institutional Review Board of Linko Chang Gung Memorial Hospital and written 
informed consent was obtained from the volunteers. HS-NPs were prepared by adding 3 mM CaCl2 and 
Na2HPO4 each into DMEM (Gibco, Carlsbad, CA) containing 10% HS, followed by incubation for one 
week in cell culture conditions (37 °C, 5% CO2, humidified air). The particles were pelleted by centrifuga-
tion at 16,000 × g for 15 min at 4 °C and washed twice with HEPES buffer (20 mM HEPES, 1 mM CaCl2, 
2 mM Na2HPO4, 150 mM NaCl) using the same centrifugation procedure.
SDS-PAGE and Western blotting. SDS-PAGE and Western blot analysis were performed essen-
tially as before15. Briefly, 0.2 μ g (Fig. 5A,D) or 1.2 μ g (Fig. 5B,C) of HS proteins, 47 μ g (Fig. 5A,B,D) or 
590 μ g of HS-NP proteins (Fig. 5C), 0.1 μ g of HSA (Fig. 5A–D), and 0.6 μ g (Fig. 5A,C,D) or 0.15 μ g of 
HSF (Fig.  5B) were dissolved in 5× “loading buffer” (0.313 M Tris-HCl pH 6.8, 10% SDS, 0.05% bro-
mophenol blue, 50% glycerol, 12.5% β -mercaptoethanol) to a final concentration of 1× , prior to heating 
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at 95 °C for 5 min and separation under denaturing and reducing conditions on a 10% SDS-PAGE using 
a mini-gel system (Hoefer, Holliston, MA). The NP control (used in lane 1 of Fig. 5A–D) consisted of 
mineral NPs prepared by adding 3 mM CaCl2 and Na2HPO4 each into DMEM (final volume of 1 ml), 
followed by incubation for one day in cell culture conditions; the particles were pelleted by centrifu-
gation at 16,000 × g for 15 min, washed twice with HEPES buffer, and resuspended in 50 μ l of HEPES 
buffer. An aliquot of 20 μ l of resuspended particles was processed for SDS-PAGE as above. PVDF mem-
branes were blocked for 1 h in 5% (w/v) defatted milk at room temperature. The primary antibodies 
generated in-house as described before25 were used at a dilution of 1:1,000 (α -apo-A1 and α -HS-NP), 
1:3,000 (α -HSF), or 1:6,000 (α -HSA). The goat anti-rabbit horseradish peroxidase-conjugated secondary 
antibody was used based on the instructions provided by the manufacturer (Millipore, Billerica, MA). 
The blots were revealed using enhanced cheluminescence (Amersham Biosciences, Amersham, UK) and 
autoradiographic films.
Immunogold labeling. Samples were prepared as for TEM observation. HS-NP blocks were sec-
tioned into slices less than 70 nm thick. Sample sections on grids were blocked with 1% fish gelatin 
(Sigma) in 0.1 M HEPES buffer (pH 8.0) for 25 min. The grids were incubated with the following pri-
mary antibodies: α -HSA, 1:30; α -HSF, 1:50; α -apo-A1, 1:30; α -HS-NP, 1:60. The negative control con-
tained no primary antibody (1% fish gelatin in HEPES buffer). The incubated sections were rinsed with 
HEPES buffer for 15 min. Rinsed sections were blocked with 1% fish gelatin in HEPES buffer for 20 min. 
The specimens were treated with the secondary 5-nm-gold-conjugate goat anti-rabbit IgG for 1 h. The 
specimens were washed with HEPES buffer for 10 min, prior to washing with ddH2O for 10 min. TEM 
observations were performed as above.
Fluorescence microscopy. Histological kidney tissue slides prepared as above were blocked with 
1% bovine serum albumin for 1 h at room temperature. The slides were incubated with primary pol-
yclonal antibodies at a dilution of 1:4,000. After washing steps, the samples were incubated with the 
secondary antibodies goat anti-rabbit-FITC (492/520 nm) and goat anti-rabbit-TRITC (550/570 nm) 
(JacksonImmuno Research, West Grove, PA) at 1:100 for 1 h. The complexes were washed with PBST for 
15 min. The fluorescent stain 4′,6-diamidino-2-phenylindole (DAPI) was used at 10 μ g/ml for 15 min. 
DAPI-stained specimens were dehydrated with 95 and 100% ethanol for 10 min each, followed by dehy-
dration in xylene for another 10 min. Dehydrated kidney specimens were mounted with Vectashield flu-
orescence H-1000 mounting medium (Vector Laboratories, Burlingame, CA) and were observed under 
a confocal microscope (LSM510 Meta; Zeiss, Oberkochen, Germany) equipped with a Spot Flex camera.
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